Xyall is a life sciences company offering an automated tissue dissection solution that bridges histopathology and molecular pathology. Its Tissector platform combines precision robotics, digital pathology, and workflow optimization to improve tissue sample selection for molecular diagnostics and personalized cancer therapy. The company positions its technology as enabling high-throughput, high-accuracy tissue preparation for use in molecular pathology workflows, with operations based in Eindhoven, the Netherlands.
No recent news for this company.